Merck and Moderna Cancer Vaccine Data: What the Podcast Preview Does—and Doesn’t—Tell Us
A podcast preview points listeners to new cancer research, but gives no trial details or results for assessing the mRNA vaccine.
Latest stories
A podcast preview points listeners to new cancer research, but gives no trial details or results for assessing the mRNA vaccine.
MRT is being marketed to older patients despite limited evidence. A clinic’s unpublished data may help clarify what the treatment can—and can’t—show.
A Washington resident with underlying health conditions died after H5N1 exposure linked to dairy cattle; the risk to the general public remains low.
Studies link some mushrooms with antioxidant, immune, blood sugar, brain and exercise effects, but much of the evidence is early or limited.
Weight regain is common after GLP-1 drugs are stopped. Research on gradual tapering is early, so plans belong in a conversation with a clinician.
Berries offer useful nutrients and flexible ways to add fruit to meals. Here’s what the research suggests, plus tips for fresh and frozen berries.
Choline supports cell function, the liver and brain, but most adults fall below its intake target. Learn what the evidence says and which foods provide it.
Iron deficiency can develop before anemia appears. Learn who may be at risk, what testing can show, and why supplements call for care.
Magnesium supports many body functions, but evidence for added health benefits varies. Learn about food sources, intake, absorption and supplement safety.
Audits and enrollment removals spotlight real fraud risks, but disputed findings and coverage changes leave questions about evidence, consistency and access.
Experimental peptides have drawn attention despite limited human research. Here’s what natural origins, treatment claims and patents do—and don’t—tell us.
A patient’s search for a lung cancer drug highlights China’s growing role in biotech and the access, evidence and safety questions patients face.
Georgia plans birth carts for 43 rural hospitals, but families and clinicians say emergency equipment can’t replace nearby maternity care.
A customs rule affecting international parcels is delayed until Jan. 20, but patients still lack clarity about access to lower-cost prescription medicines.
Premiums, deductibles and medical bills are forcing families to cut care, sell assets and take on debt, even when they have insurance.
KFF projects higher premiums and deductibles for many stand-alone drug plans in 2027. Comparing coverage during enrollment may help people understand their opti...
Research on data center health effects is still early. Residents are concerned about generator emissions, noise, lighting and water use as more projects are pro...
A proposed one-time tax could raise billions for California health care, though the amount, timing and long-term effects are unclear.
A Texas review found that many nonprofit hospitals delay financial aid screening, while patients may miss help, keep paying bills, or receive no refund.
More older adults take five or more medications. A current medication list and a review with a clinician can help identify side effects and interactions.